Submission of Audited Financial Results under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter and year ended 31 March 2025.
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare Limited filed its audited results for Q4 and FY25 on May 28, 2025. On a standalone basis, the company reported a full-year net profit of Rs. 3.99 crores (down from Rs. 5.34 crores in FY24) and a Q4 profit of Rs. 3.36 crores versus a loss of Rs. 2.49 crores in Q4 FY24. Standalone revenue from operations declined to Rs. 15.12 crores from Rs. 17.60 crores. On a consolidated basis, revenue rose modestly to Rs. 788.04 crores from Rs. 747.18 crores, but the group remained in the red with a net loss of Rs. 56.16 crores (vs Rs. 58.53 crores loss in FY24). The Board did not recommend any dividend. The statutory auditor flagged a material uncertainty on going concern citing past consecutive losses, and highlighted emphasis-of-matter items including the ongoing SFIO investigation, CSIR loan-related contingency, public fixed deposit liabilities, and assets held for sale.
For shareholders, the standalone turnaround is encouraging, but the consolidated loss position, auditor's going-concern flag, no dividend, and unresolved legal/regulatory matters (SFIO probe, sub-judice cases) are meaningful overhangs that could keep sentiment cautious.